Market Cap 242.12M
Revenue (ttm) 129.42M
Net Income (ttm) 17.38M
EPS (ttm) N/A
PE Ratio 18.97
Forward PE 23.35
Profit Margin 13.43%
Debt to Equity Ratio 0.00
Volume 322,100
Avg Vol 609,336
Day's Range N/A - N/A
Shares Out 79.64M
Stochastic %K 15%
Beta 2.09
Analysts Strong Sell
Price Target $10.10

Company Profile

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, in...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 310 388 6706
Address:
10900 Wilshire Blvd, Suite 600, Los Angeles, United States
MattManzanita
MattManzanita Sep. 13 at 6:57 AM
$NAGE mentioned recently that I interviewed a OneSpaWorld representative on a cruise ship about people who got Niagen Plus IVs. He said that it was selling very well on the ship. He said that people getting Niagen Plus IVs often came back to the spa raving about the results, and that they then started taking TruNiagen capsules "when they get home". I regretted not having asked him how he knew that the customers took capsules after they got off the ship. Apparently AI knows: OneSpaWorld tracks and knows that passengers take capsule Niagen after getting Niagen Plus IV infusions through several direct operational and retail channels. 1, 2 Because OneSpaWorld operates the onboard Medi-Spas as a highly optimized business, they do not just track the clinical treatment—they manage the entire consumer pipeline. 1, 2 Here is exactly how they capture this information: 1 Onboard Retail Sales and "Take-Home" Maintenance Kits (CONTINUED)
2 · Reply
okeydokey_artichokey
okeydokey_artichokey Sep. 13 at 4:02 AM
$NAGE Just found this Korean skincare company featuring NR. https://ayucell.com/?srsltid=AfmBOopwuvkhcPZ7aT8NA5IiDuTU4fCxZuyHmQh07g4SdKFeP-EQqk_v
0 · Reply
MattManzanita
MattManzanita Sep. 12 at 5:09 AM
$NAGE "One of the most under valued stocks...." https://www.investing.com/news/company-news/niagen-bioscience-launches-drug-candidate-for-rare-disease-93CH-4781634
0 · Reply
Jimgym
Jimgym Sep. 10 at 8:24 PM
$NAGE short interest down another 156k to 4,155,915
0 · Reply
wycliff
wycliff Sep. 10 at 1:58 PM
$NAGE https://investors.niagenbioscience.com/news/news-details/2026/Niagen-Bioscience-to-Present-at-Canaccord-Genuitys-Well-Summit/default.aspx
0 · Reply
Impalas283
Impalas283 Sep. 10 at 1:27 PM
$NAGE I don't get this skin care thing. If NR effects all trillions of cells, why do we need a skin care product?
4 · Reply
MattManzanita
MattManzanita Sep. 9 at 7:40 PM
$NAGE An AI summary of where we are regarding skincare products: which large skincare companies are interested in Niagen? Large skincare conglomerates, most notably The Estée Lauder Companies, have expressed strong interest in securing supply agreements for Niagen. The ingredient's owner, Niagen Bioscience (formerly known as ChromaDex), has heavily prioritized expansion into the multi-billion-dollar global skincare and beauty sectors. This commercial interest is driven by several key developments: 1. Supply Agreements with Conglomerates During recent investor and industry conferences, management revealed that larger skincare companies—including Estée Lauder—are actively looking into commercial supply agreements to incorporate patented Niagen (nicotinamide riboside) into their own product formulations.
1 · Reply
MattManzanita
MattManzanita Sep. 8 at 6:21 PM
$NAGE AI version of a paper published today. The trsail was sponsored by Niagen Bio.: The Main TakeawayNicotinamide riboside (NR), a supplement that boosts a vital molecule called NAD+, was found to be safe and effective at improving muscle function in a small group of human patients with genetic mitochondrial diseases.While the treatment showed general benefits for all participants, it was especially effective for a specific sub-group of patients, actually reversing some of the cellular damage in their muscles.The BreakdownThe Problem: Mitochondrial disorders are inherited diseases affecting about 1 in 8,000 people. They damage the cell's "power plants" (mitochondria), leading to a lack of energy and muscle weakness. Currently, there are no treatments that fix the underlying cause Scientists believed that taking a supplement called NR could boost a molecule called NAD+, which acts like a battery charger for mitochondria. It worked in animal models, this is the first human trail.
0 · Reply
wycliff
wycliff Sep. 8 at 5:11 PM
$NAGE https://lnkd.in/p/eNquP8zU
0 · Reply
wycliff
wycliff Sep. 6 at 6:08 AM
$NAGE https://www.reddit.com/r/NicotinamideRiboside/s/VFxXhkuqxn
0 · Reply
Latest News on NAGE
Niagen Bioscience Earnings Call Transcript: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 5 weeks ago

Niagen Bioscience Earnings Call Transcript: Q2 2026


Niagen Bioscience Earnings release: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 5 weeks ago

Niagen Bioscience Earnings release: Q2 2026


Niagen Bioscience Quarterly report: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 5 weeks ago

Niagen Bioscience Quarterly report: Q2 2026


Niagen Bioscience Slides: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 5 weeks ago

Niagen Bioscience Slides: Q2 2026


Niagen Bioscience reports Q2 EPS 1c vs 4c last year

2026-08-04T20:05:37.000Z - 5 weeks ago

Niagen Bioscience reports Q2 EPS 1c vs 4c last year


Niagen Bioscience Transcript: Fireside chat

Jul 15, 2026, 11:00 AM EDT - 1 month ago

Niagen Bioscience Transcript: Fireside chat


Niagen Bioscience Slides: Corporate presentation

Jul 15, 2026, 7:00 AM EDT - 2 months ago

Niagen Bioscience Slides: Corporate presentation


Niagen Bioscience initiated with a Buy at Freedom Broker

2026-07-06T19:10:21.000Z - 2 months ago

Niagen Bioscience initiated with a Buy at Freedom Broker


Niagen Bioscience Registration statement: Registration filing

Jun 29, 2026, 8:00 AM EDT - 2 months ago

Niagen Bioscience Registration statement: Registration filing


Niagen Bioscience files $125M mixed securities shelf

2026-06-29T10:25:42.000Z - 2 months ago

Niagen Bioscience files $125M mixed securities shelf


Niagen Bioscience renames CERP to Niagen Research Program

2026-06-02T15:25:33.000Z - 3 months ago

Niagen Bioscience renames CERP to Niagen Research Program


Niagen Bioscience Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 4 months ago

Niagen Bioscience Earnings Call Transcript: Q1 2026


Niagen Bioscience Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 4 months ago

Niagen Bioscience Quarterly report: Q1 2026


Niagen Bioscience Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 4 months ago

Niagen Bioscience Earnings release: Q1 2026


Niagen Bioscience Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 4 months ago

Niagen Bioscience Slides: Q1 2026


Niagen Bioscience Slides: Corporate presentation

May 6, 2026, 7:00 AM EDT - 4 months ago

Niagen Bioscience Slides: Corporate presentation


Niagen Bioscience Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Niagen Bioscience Proxy statement: Proxy filing


Niagen Bioscience Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Niagen Bioscience Proxy statement: Proxy filing


Niagen Bioscience to Present at the 38th Annual ROTH Conference

Mar 18, 2026, 8:32 AM EDT - 5 months ago

Niagen Bioscience to Present at the 38th Annual ROTH Conference


Niagen Bioscience Earnings Call Transcript: Q4 2025

Mar 4, 2026, 4:30 PM EST - 6 months ago

Niagen Bioscience Earnings Call Transcript: Q4 2025


Niagen Bioscience Annual report: Q4 2025

Mar 4, 2026, 4:30 PM EST - 6 months ago

Niagen Bioscience Annual report: Q4 2025


Niagen Bioscience Earnings release: Q4 2025

Mar 4, 2026, 4:30 PM EST - 6 months ago

Niagen Bioscience Earnings release: Q4 2025


Niagen Bioscience Slides: Q4 2025

Mar 4, 2026, 4:30 PM EST - 6 months ago

Niagen Bioscience Slides: Q4 2025


Niagen Bioscience Slides: Corporate presentation

Mar 4, 2026, 7:00 AM EST - 6 months ago

Niagen Bioscience Slides: Corporate presentation


Niagen Bioscience Announces $10 Million Share Repurchase Program

Nov 6, 2025, 8:07 AM EST - 10 months ago

Niagen Bioscience Announces $10 Million Share Repurchase Program


Niagen Bioscience Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

Niagen Bioscience Earnings Call Transcript: Q3 2025


Niagen Bioscience Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

Niagen Bioscience Earnings release: Q3 2025


Niagen Bioscience Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

Niagen Bioscience Quarterly report: Q3 2025


Niagen Bioscience Slides: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

Niagen Bioscience Slides: Q3 2025


Niagen Bioscience Slides: Investor presentation

Nov 4, 2025, 7:00 AM EST - 10 months ago

Niagen Bioscience Slides: Investor presentation


Niagen Bioscience Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Niagen Bioscience Earnings Call Transcript: Q2 2025


Niagen Bioscience Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Niagen Bioscience Earnings release: Q2 2025


Niagen Bioscience Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Niagen Bioscience Quarterly report: Q2 2025


Niagen Bioscience Slides: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Niagen Bioscience Slides: Q2 2025


MattManzanita
MattManzanita Sep. 13 at 6:57 AM
$NAGE mentioned recently that I interviewed a OneSpaWorld representative on a cruise ship about people who got Niagen Plus IVs. He said that it was selling very well on the ship. He said that people getting Niagen Plus IVs often came back to the spa raving about the results, and that they then started taking TruNiagen capsules "when they get home". I regretted not having asked him how he knew that the customers took capsules after they got off the ship. Apparently AI knows: OneSpaWorld tracks and knows that passengers take capsule Niagen after getting Niagen Plus IV infusions through several direct operational and retail channels. 1, 2 Because OneSpaWorld operates the onboard Medi-Spas as a highly optimized business, they do not just track the clinical treatment—they manage the entire consumer pipeline. 1, 2 Here is exactly how they capture this information: 1 Onboard Retail Sales and "Take-Home" Maintenance Kits (CONTINUED)
2 · Reply
okeydokey_artichokey
okeydokey_artichokey Sep. 13 at 4:02 AM
$NAGE Just found this Korean skincare company featuring NR. https://ayucell.com/?srsltid=AfmBOopwuvkhcPZ7aT8NA5IiDuTU4fCxZuyHmQh07g4SdKFeP-EQqk_v
0 · Reply
MattManzanita
MattManzanita Sep. 12 at 5:09 AM
$NAGE "One of the most under valued stocks...." https://www.investing.com/news/company-news/niagen-bioscience-launches-drug-candidate-for-rare-disease-93CH-4781634
0 · Reply
Jimgym
Jimgym Sep. 10 at 8:24 PM
$NAGE short interest down another 156k to 4,155,915
0 · Reply
wycliff
wycliff Sep. 10 at 1:58 PM
$NAGE https://investors.niagenbioscience.com/news/news-details/2026/Niagen-Bioscience-to-Present-at-Canaccord-Genuitys-Well-Summit/default.aspx
0 · Reply
Impalas283
Impalas283 Sep. 10 at 1:27 PM
$NAGE I don't get this skin care thing. If NR effects all trillions of cells, why do we need a skin care product?
4 · Reply
MattManzanita
MattManzanita Sep. 9 at 7:40 PM
$NAGE An AI summary of where we are regarding skincare products: which large skincare companies are interested in Niagen? Large skincare conglomerates, most notably The Estée Lauder Companies, have expressed strong interest in securing supply agreements for Niagen. The ingredient's owner, Niagen Bioscience (formerly known as ChromaDex), has heavily prioritized expansion into the multi-billion-dollar global skincare and beauty sectors. This commercial interest is driven by several key developments: 1. Supply Agreements with Conglomerates During recent investor and industry conferences, management revealed that larger skincare companies—including Estée Lauder—are actively looking into commercial supply agreements to incorporate patented Niagen (nicotinamide riboside) into their own product formulations.
1 · Reply
MattManzanita
MattManzanita Sep. 8 at 6:21 PM
$NAGE AI version of a paper published today. The trsail was sponsored by Niagen Bio.: The Main TakeawayNicotinamide riboside (NR), a supplement that boosts a vital molecule called NAD+, was found to be safe and effective at improving muscle function in a small group of human patients with genetic mitochondrial diseases.While the treatment showed general benefits for all participants, it was especially effective for a specific sub-group of patients, actually reversing some of the cellular damage in their muscles.The BreakdownThe Problem: Mitochondrial disorders are inherited diseases affecting about 1 in 8,000 people. They damage the cell's "power plants" (mitochondria), leading to a lack of energy and muscle weakness. Currently, there are no treatments that fix the underlying cause Scientists believed that taking a supplement called NR could boost a molecule called NAD+, which acts like a battery charger for mitochondria. It worked in animal models, this is the first human trail.
0 · Reply
wycliff
wycliff Sep. 8 at 5:11 PM
$NAGE https://lnkd.in/p/eNquP8zU
0 · Reply
wycliff
wycliff Sep. 6 at 6:08 AM
$NAGE https://www.reddit.com/r/NicotinamideRiboside/s/VFxXhkuqxn
0 · Reply
wycliff
wycliff Sep. 5 at 9:05 AM
$NAGE https://lnkd.in/p/ePwgi3f3
0 · Reply
Impalas283
Impalas283 Sep. 3 at 2:57 PM
$NAGE For well over a year now, this stock has done nothing but decline. Many analyst's short and long term price predictions are bad, and management doesn't seem to care.
1 · Reply
wycliff
wycliff Sep. 2 at 5:51 PM
$NAGE https://lnkd.in/p/eRpCMzrb
0 · Reply
wycliff
wycliff Sep. 2 at 5:14 PM
$NAGE https://lnkd.in/p/e9cR5kAV
0 · Reply
wycliff
wycliff Sep. 2 at 3:31 PM
$NAGE https://investors.niagenbioscience.com/news/news-details/2026/Niagen-Bioscience-to-Present-at-Longevity-Investors-Conference/default.aspx
0 · Reply
Impalas283
Impalas283 Sep. 1 at 2:28 PM
$NAGE Just imagine what would happen to this stock if there was an issue with their only supplier.
2 · Reply
okeydokey_artichokey
okeydokey_artichokey Sep. 1 at 3:13 AM
$NAGE well worth one's time https://www.cell.com/cell-reports/fulltext/S2211-1247(26)00927-7?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124726009277%3Fshowall%3Dtrue
1 · Reply
SnowyDingo
SnowyDingo Aug. 31 at 2:53 PM
$NAGE like clockwork drops on open and huge spikes at close
1 · Reply
wycliff
wycliff Aug. 31 at 1:41 PM
$NAGE https://x.com/charlesmbrenner/status/2094317429069390245?s=42
0 · Reply
Impalas283
Impalas283 Aug. 31 at 12:18 PM
$NAGE Who wants to wait until 2030 for "possible approval" of their pharmaceutical efforts?
2 · Reply
wycliff
wycliff Aug. 31 at 1:03 AM
$NAGE https://www.investing.com/news/transcripts/niagen-bioscience-at-midwest-ideas-cashrich-growth-and-drug-bets-93CH-4880180
1 · Reply
wycliff
wycliff Aug. 29 at 4:02 PM
$NAGE https://www.truniagen.com/blogs/tru-niagen-labs/what-2-5-years-looks-like-in-muscle-tissue
0 · Reply